Akero Therapeutics Stock Doubles on Liver Data
The data appeared to slam the door on the idea that the advent of GLP-1 drugs would eliminate demand for drugs specifically ...
Cantor maintains LRCX target, sees modest Q4 beats
Cantor Fitzgerald maintained a positive outlook on Lam Research (NASDAQ:LRCX) and KLA Corp. (NASDAQ:KLAC) stocks, ...